The initial public offering (IPO) market has been a barren wasteland lately, but investors now have something to look forward to. Johnson & Johnson announced that its consumer health spinoff company Kenvue will IPO later this year.
Kenvue will be valued around $40 billion by the time of the IPO. And it could be the largest IPO this year.
In this episode of Startup Insider, Vin Narayanan explains why this is a good opportunity for investors to gauge market interest in IPOs.
Thanks for watching!